For KAUST, KFUPM, KSU, KAU, PNU, KACST, NCAI — and every research office sitting on IP that deserves a product.
Most research IP in MENA never becomes a product. The gap between "paper published" and "company operating" is not funding — it is a commercialization engine with AI-native product skill, Saudi market access, and the patience to work with tech-transfer offices. We are that engine.
Saudi universities now hold substantial AI and applied-research IP that maps cleanly onto Vision 2030 demand (health, fintech, energy, public sector AI). But research offices are not product teams, and the commercialization path is long. The B2IP partnership shortens it to 12–18 months with shared equity — the researchers keep the science and a stake in the venture.
We take the IP, build the product around it, go to market, and hand the founders the keys. Research teams do not become founders by accident — we make the path deliberate.
Research institution + researchers + Projex Labs co-own the resulting venture. The commercialization partnership is an equity partnership, not a service contract.
We prioritize IP in verticals with structural government demand: clinical AI (Hakeem), Arabic NLP, sovereign cloud tooling, fintech compliance. Your IP lands where buyers are already mandated to procure.
Every B2IP venture gets the full Projex Labs stack: open-core product architecture, compliance posture, and the same engineering discipline we use on our internal ventures.
Email or LinkedIn — we respond within 48h with a structured next step.